These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 23361)

  • 1. [Pharmacologic functional examination in arterial hypertension].
    Stumpe KO; Kolloch R; Overlack A
    Internist (Berl); 1977 Nov; 18(11):594-600. PubMed ID: 23361
    [No Abstract]   [Full Text] [Related]  

  • 2. [Angiotensin blockade in the diagnosis of hypertension].
    Keim HJ; Case DB; Wallace JM; Sealry JE; Laragh JH
    Verh Dtsch Ges Kreislaufforsch; 1977; 43():205-6. PubMed ID: 613573
    [No Abstract]   [Full Text] [Related]  

  • 3. [Use of specific angiotensin inhibitors in the diagnosis and treatment of arterial hypertension].
    Novikova LS; Arabidze GG
    Ter Arkh; 1979; 51(5):99-108. PubMed ID: 222004
    [No Abstract]   [Full Text] [Related]  

  • 4. [Diagnostic and therapeutic significance of antagonists of the renin-angiotensin system (author's transl)].
    Stumpe KO; Overlack A; Krück F
    Herz; 1978 Oct; 3(5):305-12. PubMed ID: 721057
    [No Abstract]   [Full Text] [Related]  

  • 5. [Angiotensin II inhibitors for the diagnosis and treatment of hypertension].
    Brunner HR; Gavras H
    Schweiz Med Wochenschr; 1976 Dec; 106(50):1791-8. PubMed ID: 1013701
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outpatient experience with saralasin.
    Streeten DH; Anderson GH
    Kidney Int Suppl; 1979 Mar; (9):S44-52. PubMed ID: 289863
    [No Abstract]   [Full Text] [Related]  

  • 7. [Differential diagnosis of hypertension using the angiotensin II antagonist saralasin].
    Knauf H; Burmeister P; Büttner C; Hoppe-Seyler G; Schollmeyer P
    Verh Dtsch Ges Kreislaufforsch; 1977; 43():214-5. PubMed ID: 613578
    [No Abstract]   [Full Text] [Related]  

  • 8. Hypertension, the adrenal and the kidney: lessons from pharmacologic interruption of the renin-angiotensin system.
    Hollenberg NK; Williams GH
    Adv Intern Med; 1980; 25():327-61. PubMed ID: 6153859
    [No Abstract]   [Full Text] [Related]  

  • 9. Renin release, saralasin and the vasodilator-beta-blocker drug interaction in man.
    Pettinger WA; Mitchell HC
    N Engl J Med; 1975 Jun; 292(23):1214-7. PubMed ID: 236513
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The saralasin test in the diagnosis of hypertension (author's transl)].
    Bönner G; Helber A; Meurer KA; Hummerich W; Wambach G; Kaufmann W
    Dtsch Med Wochenschr; 1979 Mar; 104(12):432-7. PubMed ID: 436589
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A role for renin in rebound hypertension and encephalopathy after infusion of saralasin acetate (Sar1-Ala8-angiotensin II).
    Keim HJ; Drayer JI; Case DB; Lopez-Ovejero J; Wallace JM; Weber MA; Laragh JH
    N Engl J Med; 1976 Nov; 295(21):1175-7. PubMed ID: 980020
    [No Abstract]   [Full Text] [Related]  

  • 12. [The Saralasin test in the diagnosis of renovascular hypertension. Personal experience].
    Giuliani L; Martorana G; Giberti C
    Minerva Nefrol; 1979; 26(4):623-8. PubMed ID: 396491
    [No Abstract]   [Full Text] [Related]  

  • 13. Hypertension screening and treatment with angiotensin inhibitors. Saralasin and captopril.
    Zawada ET; Stinson J; Ramirez G
    Postgrad Med; 1980 Oct; 68(4):89-92, 94-5, 98. PubMed ID: 6999479
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of an angiotensin II antagonist (saralasin) in the recognition of "angiotensinogenic" hypertension;
    Streeten DH; Anderson GH; Freiberg JM; Dalakos TG
    N Engl J Med; 1975 Mar; 292(13):657-62. PubMed ID: 235090
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blockade of renin or angiotensin for understanding human hypertension: a comparison of propranolol, saralasin and converting enzyme blockade.
    Laragh JH; Case DB; Wallace JM; Keim H
    Fed Proc; 1977 Apr; 36(5):1781-7. PubMed ID: 191300
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Significance of the saralasin infusion test in the diagnosis of arterial hypertension].
    Glorioso N; Madeddu P; Dessì-Fulgheri P; Meloni F; Palermo M; Fiori C; Rappelli A
    Boll Soc Ital Cardiol; 1980; 25(9):1035-46. PubMed ID: 7025868
    [No Abstract]   [Full Text] [Related]  

  • 17. Clinical evaluation of renovascular hypertension and therapeutic decisions.
    Vaughan ED; Case DB; Pickering TG; Sosa RE; Sos TA; Laragh JH
    Urol Clin North Am; 1984 Aug; 11(3):393-407. PubMed ID: 6205495
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical usefulness of saralasin in human hypertension (author's transl)].
    Fouchard M; Bichara M; Grüfeld JP; Barbanel C; Meyer P; Funck-Brentano JL
    Nouv Presse Med; 1978 Feb; 7(7):539-43. PubMed ID: 643579
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Saralasin infusion in renovascular and essential hypertension.
    Thien T; Hoefnagels WH
    Neth J Med; 1980; 23(2):68-73. PubMed ID: 6990282
    [No Abstract]   [Full Text] [Related]  

  • 20. [Significance of renin-angiotensin system inhibitors in the diagnosis of hypertension].
    Stumpe KO; Kolloch RE; Overlack A
    Med Welt; 1977 Oct; 28(41):1645-9. PubMed ID: 927124
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.